To assess the role of different combinations of (oncoplastic) surgery and radiotherapy techniques as risk factors for moderate to severe fibrosis and for moderate to poor cosmetic outcome.
The primary objectives of this study are to assess the role of different combinations of (oncoplastic) surgery and radiotherapy techniques as risk factors for moderate to severe fibrosis and for moderate to poor cosmetic outcome. Based on these insights predictive models for the development of moderate to severe fibrosis and moderate to poor cosmetic outcome will be developed. Second, the relation between the presence and severity of fibrosis, cosmetic outcome and different QoL domains and symptoms will be assessed.
Study Type
OBSERVATIONAL
Enrollment
775
At one timepoint patients will get physical examination of the breasts, medical photographs will be taken, and they will fill in five questionnaires about satisfaction of the breasts, quality of life and general health.
Albert Schweitzer hospital
Dordrecht, Netherlands
Erasmus Medical Center
Rotterdam, Netherlands
Maasstad hospital
Rotterdam, Netherlands
Franciscus Gasthuis & Vlietland
Schiedam, Netherlands
Fibrosis of the breast as measured by CTCAE v5 scale
Fibrosis will be graded by the researcher using the CTCAE v5 scale. On the CTCAE scale of superficial soft tissue fibrosis: Grade 0 = no fibrosis, Grade 1 = mild induration, able to move skin parallel to plane (sliding) and perpendicular to skin (pinching up), Grade 2 = Moderate induration, able to slide skin, unable to pinch skin; limiting instrumental ADL, Grade 3 = Severe induration; unable to slide or pinch skin; limiting joint or orifice movement (e.g., mouth, anus); limiting self care ADL, Grade 4 = Generalized; associated with signs or symptoms of impaired breathing or feeding, Grade 5 = Death. We are planning to score fibrosis of the breast as none/mild (grade 0-1) or moderate/severe (grade 2-3).
Time frame: 2-6 years after breast conserving treatment. 1 point of measurement.
Cosmetic outcome as measured by 9-item questionnaire
Cosmetic outcome will be evaluated by means of a 9-item cosmetic patient questionnaire filled out by the patient with scoring on a four point scale (range from 'excellent' to 'poor' per item).
Time frame: 2-6 years after breast conserving treatment. 1 point of measurement.
Cosmetic outcome as measured by BCCT.core software
Patients' photographs of the breasts will be taken. With the use of BCCT.core software from The Breast Research group (INESC TEC, the Faculdade de Medicina da Universidade do Porto) cosmetic outcome will be assessed.
Time frame: 2-6 years after breast conserving treatment. 1 point of measurement.
Quality of life, as measured by BREAST-Q
Which includes the following domains: psychosocial well being, sexual well being, satisfaction with the breasts, physical well being, adverse effects of radiation. All domains are scored 0 to 100 points, higher points means a better outcome.
Time frame: 2-6 years after breast conserving treatment. 1 point of measurement.
Quality of life, as measured by EORTC Quality of Life Questionnaires-C30
Which include functional domains, global health status and symptom scales. For functional domains and global health status, scores range from 0 to 100. Higher scores means a better level of functioning. For symptoms scales, scores range from 0 to 100. Higher scores represent a greater degree of symptoms.
Time frame: 2-6 years after breast conserving treatment. 1 point of measurement.
Quality of life, as measured by EORTC Quality of Life Questionnaires-B23
Which include functional domains, global health status and symptom scales. For functional domains and global health status, scores range from 0 to 100. Higher scores means a better level of functioning. For symptoms scales, scores range from 0 to 100. Higher scores represent a greater degree of symptoms.
Time frame: 2-6 years after breast conserving treatment. 1 point of measurement.
Quality of life, as measured by EQ-5D-5L - five dimensions
The EQ-5D-5L include five questions about five dimensions: mobility, self-care, daily activities, pain/discomfort and anxiety/depression. For each dimension, participants choose one of five levels that best fits their health on that day (from 'no problem'= 1 to 'unable/extreme'= 5). The numbers chosen for the five dimensions are combined to give a 5 digit score (minimum score = 11111 maximum score = 55555).
Time frame: 2-6 years after breast conserving treatment. 1 point of measurement.
Quality of life, as measured by EQ-5D-5L - VAS
The EQ-5D-5L include, apart from the five questions about five dimensions (see above), a visual analogue scale (VAS). The VAS provides rating of the participant's health on a scale from 0 ('the worst health you can imagine') to 100 ('the best health you can imagine').
Time frame: 2-6 years after breast conserving treatment. 1 point of measurement.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.